A. O. Smith Corporation AOS recently announced that it has signed a definitive deal with Unilever PLC UL to acquire the latter’s Pureit unit for about $120 million in cash. The acquisition is expected to be completed by the end of this year, subject to the fulfillment of certain customary closing conditions. AOS’ shares remained relatively stable yesterday and closed the trading session at $87.80. Unilever’s brand Pureit provides a wide range of residential water purification solutions in India. Pureit is well-known for its advanced RO & UV water purifiers that offer safe and healthy drinking water to households. The business generated revenues of roughly $60 million in 2023. Acquisition Rationale The latest buyout is in sync with A. O. Smith’s policy of acquiring businesses to strengthen its business and product portfolio. The inclusion of Pureit’s expertise in water treatment solutions, coupled with its strong brand recognition, will enable AOS to expand its customer offerings and boost its position in the water treatment industry in India. Apart from enhancing A. O. Smith’s premium product portfolio, the buyout will also strengthen its distribution capabilities. The buyout is not expected to have any material impact on AOS’ earnings in the first year. Zacks Rank & Price Performance A. O. Smith, with a $12.9 billion market capitalization, currently carries a Zacks Rank #3 (Hold). The company is likely to benefit from the solid demand for its products, contribution from acquired assets and focus on operational execution. However, challenges in the Chinese real estate market remain a concern. Zacks Investment Research Image Source: Zacks Investment Research The company’s shares have gained 8.3% in the past six months. The Zacks Consensus Estimate for AOS’ 2024 earnings has been stable at $4.08 over the last 60 days. It has a trailing four-quarter average earnings surprise of 6.7%. Stocks to Consider A couple of better-ranked stocks from the industry are presented below. Enersys ENS presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. ENS delivered a trailing four-quarter average earnings surprise of 2.7%. In the past 60 days, the Zacks Consensus Estimate for Enersys’ fiscal 2025 (ending March 2025) earnings has increased 3.9%. Emerson Electric Co. EMR presently carries a Zacks Rank #2 (Buy). EMR delivered a trailing four-quarter average earnings surprise of 10.7%. In the past 60 days, the consensus estimate for its 2024 earnings has risen 0.7%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Unilever PLC (UL):Free Stock Analysis Report Emerson Electric Co. (EMR):Free Stock Analysis Report A. O. Smith Corporation (AOS):Free Stock Analysis Report Enersys (ENS):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
A. O. Smith (AOS) to Buy Pureit & Expand Presence in India
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...